Zika Virus NS3 Mimics a Cellular 14-3-3-Binding Motif to Antagonize RIG-I- and MDA5-Mediated Innate Immunity

William Riedl1, Dhiraj Acharya1, Jung-Hyun Lee1

  • 1Department of Microbiology, The University of Chicago, Chicago, IL 60637, USA.

Cell Host & Microbe
|October 11, 2019
PubMed

Insights

Zika virus NS3 protein blocks antiviral signaling by binding 14-3-3 proteins, which are essential for RIG-I-like receptor function. Disrupting this interaction enhances immune responses and hinders viral growth, offering insights for therapies.

Area of Science:

  • Immunology
  • Virology
  • Molecular Biology

Background:

  • 14-3-3 proteins are crucial for RLR signaling, mediating interferon production.
  • 14-3-3ϵ and 14-3-3η facilitate RIG-I and MDA5 translocation to mitochondria, respectively.
  • Zika virus (ZIKV) evades host immunity through viral proteins like NS3.

Purpose of the Study:

  • To investigate the mechanism by which ZIKV NS3 antagonizes RLR-mediated antiviral signaling.
  • To elucidate the role of 14-3-3 proteins in ZIKV immune evasion.

Main Methods:

  • Biochemical assays to study protein-protein interactions between ZIKV NS3 and 14-3-3 proteins.
  • Site-directed mutagenesis to disrupt the 14-3-3 binding motif in ZIKV NS3.
  • Analysis of antiviral gene induction and viral replication in cells and recombinant ZIKV models.

Main Results:

  • ZIKV NS3 protein binds and sequesters 14-3-3ϵ and 14-3-3η, inhibiting RLR signaling.
  • A conserved negatively charged RLDP motif in NS3 mediates 14-3-3 binding.
  • Mutating the 14-3-3 binding site in ZIKV NS3 enhances innate immune responses and reduces viral growth.

Conclusions:

  • ZIKV NS3 employs a conserved motif to antagonize host antiviral immunity by disrupting RLR-14-3-3 interactions.
  • Understanding this immune evasion strategy provides a basis for developing ZIKV vaccines and antiviral therapies.